Inactive Instrument

ALPA HEAL Stock

AHAC

US0207511033

Analysts' recommendations: ALPA HEAL

21-07-20	ALPHA HEALTHCARE ACQUISITION : Benchmark Capital Starts Alpha Healthcare Acquisition at Buy with $18 Price Target	MT
21-04-09	ALPHA HEALTHCARE ACQUISITION : Lake Street Starts Alpha Healthcare Acquisition at Buy with $20 Price Target	MT

More recommendations

Alpha Healthcare Acquisition Corp is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It intends to source, acquire and manage a business in the healthcare industry in the United States. It has not commenced any operations.

Employees

Sector

More about the company

21-08-26	Alpha Healthcare Acquisition Corp.(NasdaqCM:AHAC) dropped from NASDAQ Composite Index	CI
21-08-25	Humacyte, Inc. completed the acquisition of Alpha Healthcare Acquisition Corp. from a group of shareholders in a reverse merger transaction.	CI
21-08-24	Alpha Healthcare Acquisition : Receives Shareholder Approval for Humacyte Deal	MT
21-08-16	Alpha Healthcare Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	CI
21-07-20	ALPHA HEALTHCARE ACQUISITION : Benchmark Capital Starts Alpha Healthcare Acquisition at Buy with $18 Price Target	MT
21-05-19	Alpha Healthcare Acquisition : Humacyte Names Dale Sander as CFO	MT
21-05-17	Alpha Healthcare Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	CI
21-04-09	ALPHA HEALTHCARE ACQUISITION : Lake Street Starts Alpha Healthcare Acquisition at Buy with $20 Price Target	MT
21-03-15	Certain Class B Common Stock of Alpha Healthcare Acquisition Corp. are subject to a Lock-Up Agreement Ending on 16-MAR-2021.	CI
21-02-17	Alpha Healthcare Acquisition : to Combine With Humacyte	MT
21-02-16	Humacyte, Inc. entered into a non-binding term sheet to acquire Alpha Healthcare Acquisition Corp. from a group of shareholders in a reverse merger transaction for approximately $990 million.	CI
20-12-03	Alpha Healthcare Acquisition Corp.(NasdaqCM:AHAC) added to NASDAQ Composite Index	CI
20-09-17	Alpha Healthcare Acquisition Corp. has completed an IPO in the amount of $100 million.	CI

21-08-30	ALPA HEAL : Report of Independent Registered Public Accounting Firm (Form 8-K)	PU
21-08-26	Alpha Healthcare Acquisition : Humacyte Announces Successful Closing of Business Combination with Alpha Healthcare Acquisition Corp.	AQ
21-08-25	Alpha Healthcare Acquisition : Announces Shareholder Approval of Business Combination with Humacyte (Form 8-K)	PU
21-08-25	ALPHA HEALTHCARE ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
21-08-17	Alpha Healthcare Acquisition : Humacyte Announces Addition of Chief Commercial Officer and Integration of Commercial-Scale Manufacturing into Clinical Trial Programs (Form 8-K)	PU

Date	Insider	Type	Main position	Quantity	% Market Cap.
20-09-21	Rajiv Sarman Shukla	Others	Chief Executive Officer	305,000	-
20-09-16	Terrance L. Carlson	Other	Director	25,000	0.8696%
20-09-16	Yi Li Xie	Other	Director	25,000	0.8696%

ALPA HEAL Stock

Stocks

AHAC

US0207511033

Latest news : ALPA HEAL

Analysts' recommendations: ALPA HEAL

Press Releases: ALPA HEAL

Quotes and Performance

Latest insider transactions

Company Profile